Altimmune Inc (ALT)
8.455
-1.06
(-11.19%)
USD |
NASDAQ |
Nov 14, 16:00
8.43
-0.02
(-0.30%)
After-Hours: 07:08
Altimmune Net Income (TTM): -101.35M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -101.35M |
| March 31, 2024 | -92.77M |
| December 31, 2023 | -88.45M |
| September 30, 2023 | -78.47M |
| June 30, 2023 | -81.31M |
| March 31, 2023 | -85.36M |
| December 31, 2022 | -84.71M |
| September 30, 2022 | -86.94M |
| June 30, 2022 | -96.94M |
| March 31, 2022 | -101.66M |
| December 31, 2021 | -97.09M |
| September 30, 2021 | -83.82M |
| June 30, 2021 | -68.08M |
| March 31, 2021 | -60.02M |
| December 31, 2020 | -49.04M |
| September 30, 2020 | -42.52M |
| June 30, 2020 | -35.69M |
| March 31, 2020 | -22.31M |
| December 31, 2019 | -20.52M |
| September 30, 2019 | -40.93M |
| June 30, 2019 | -32.34M |
| March 31, 2019 | -38.09M |
| December 31, 2018 | -39.17M |
| September 30, 2018 | -23.49M |
| June 30, 2018 | -51.05M |
| Date | Value |
|---|---|
| March 31, 2018 | -45.02M |
| December 31, 2017 | -46.43M |
| September 30, 2017 | -40.66M |
| June 30, 2017 | -15.55M |
| March 31, 2017 | -14.05M |
| December 31, 2016 | -10.70M |
| September 30, 2016 | -8.877M |
| June 30, 2016 | -5.407M |
| March 31, 2016 | -6.131M |
| December 31, 2015 | -3.441M |
| September 30, 2015 | -4.832M |
| June 30, 2015 | -8.135M |
| March 31, 2015 | -6.234M |
| December 31, 2014 | -9.955M |
| September 30, 2014 | -11.75M |
| June 30, 2014 | -11.07M |
| March 31, 2014 | -11.87M |
| December 31, 2013 | -11.72M |
| September 30, 2013 | -8.563M |
| June 30, 2013 | -4.831M |
| March 31, 2013 | -4.352M |
| December 31, 2012 | -4.920M |
| September 30, 2012 | -2.901M |
| June 30, 2012 | -2.721M |
| March 31, 2012 | -4.402M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-101.66M
Minimum
Mar 2022
-20.52M
Maximum
Dec 2019
-72.48M
Average
-83.82M
Median
Sep 2021
Net Income (TTM) Benchmarks
| Eli Lilly and Co | 8.370B |
| Viking Therapeutics Inc | -99.15M |
| Amgen Inc | 4.23B |
| Avid Bioservices Inc | -144.16M |
| NovaBay Pharmaceuticals Inc | -10.12M |